TEST BANK FOR Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Teri Moser Woo and Wendy L. Wright ISBN:9781719648035 COMPLETE GUIDE ALL CHAPTERS COVERED 100% VERIFIED A+ GRADE ASSURED!!!!! NEW LATEST UPDATE!!!!!

TESTBANK
PharmacotherapeuticsforAdvancedPracticeNursePrescribers,6thEdition
m
v m
v m
v m
v




Author:Teri Moser Woo and WendyL. Wright
m
v mv m
v mv mv m
v mv

, TABLE OF CONTENT mv mv




Chapter 1. The Role of the Advanced Practice Nurse as Prescriber .........................................................................4
mv mv mv mv mv mv mv mv mv mv




Chapter 2. Review of Basic Principles of Pharmacology ........................................................................................5
mv mv mv mv lc mv mv




Chapter 3. Rational Drug Selection ..................................................................................................................... 11
mv mv mv mv




Chapter 4. Legal and Professional Issues in Prescribing ...................................................................................... 14
mv mv mv lc mv mv mv




Chapter 5. Adverse Drug Reactions ..................................................................................................................... 16
mv mv mv mv




Chapter 6. An Introduction to Pharmacogenomics .............................................................................................. 19
mv mv mv mv mv




Chapter 7. Nutrition and Nutraceuticals ............................................................................................................... 22
mv mv mv lc




Chapter 8. Herbal Therapies ................................................................................................................................ 28
mv mv mv




Chapter 9. Cannabis ............................................................................................................................................. 31
mv mv




Chapter 10. Pharmacoeconomics ......................................................................................................................... 35
mv mv




Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................ 38
mv mv mv mv mv mv mv




Chapter 12. Drugs Affecting the Central Nervous System................................................................................... 45
mv mv mv mv mv mv mv




Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems .................................................................. 53
mv mv mv mv mv mv mv mv




Chapter 14. Drugs Affecting the Respiratory System .......................................................................................... 61
mv mv mv mv mv mv




Chapter 15. Drugs Affecting the Hematological System ..................................................................................... 65
mv mv mv mv mv mv




Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ........................................... 69
mv mv mv mv mv mv mv mv mv




Chapter 17. Drugs Affecting the Immune System: Immunomodulators .............................................................. 75
mv mv mv mv mv mv mv




Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................... 77
mv mv mv mv mv mv




Chapter19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ........................ 80
m
v lc mv lc m
v m
v mv mv lc




Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .............................. 83
mv mv mv mv mv mv mv mv mv mv mv




Chapter 21. Drugs Affecting the Reproductive System ....................................................................................... 86
mv mv mv mv mv mv




Chapter 22. Drugs Affecting the Bones and Joints............................................................................................... 92
mv mv mv mv mv mv mv




Chapter 23. Drugs Affecting the Integumentary System ..................................................................................... 96
mv mv mv mv mv mv




Chapter 24. Drugs Used to Treat Bacterial Infections .........................................................................................101
mv mv mv mv mv mv mv




Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..........................................................105
mv mv mv mv mv mv mv mv mv mv




Chapter 26. Drugs Used to Treat Inflammatory Processes..................................................................................108
mv mv mv mv mv lc mv




Chapter 27. Drugs Used to Treat Eye and Ear Disorders.....................................................................................111
mv mv mv mv mv mv mv mv mv




Chapter 28. Anemia ............................................................................................................................................113
mv mv




Chapter 29. Anxiety and Depression ..................................................................................................................116
mv mv mv mv




Chapter 30. Attention Deficit-Hyperactivity Disorder .......................................................................................120
mv mv mv mv




Chapter 31. Asthma and Allergy .........................................................................................................................122
mv mv mv mv




Chapter 32. Chronic Obstructive Pulmonary Disease.........................................................................................125
mv mv mv mv mv




Chapter 33. Contraception ..................................................................................................................................127
mv mv




Chapter 34. COVID-19: Acute and Chronic .......................................................................................................130
mv mv mv mv mv




Chapter 35. Dermatological Conditions .............................................................................................................134
mv mv mv




Chapter 36. Diabetes Management .....................................................................................................................138
mv mv mv




Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ........................................................................146
mv mv mv mv mv mv mv




Chapter 38. Headaches .......................................................................................................................................149
mv mv




Chapter 39. Heart Failure ....................................................................................................................................153
mv mv lc




Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ..............................................................158
mv mv mv mv mv mv mv




Chapter 41. Menopausal Hormone Therapy .......................................................................................................161
mv mv mv mv

,Chapter 42. Hyperlipidemia ................................................................................................................................164
mv mv




Chapter 43. Hypertension ...................................................................................................................................169
mv mv




Chapter 44. Hyperthyroidism and Hypothyroidism ............................................................................................174
mv mv mv lc




Chapter 45. Obesity ............................................................................................................................................177
mv mv




Chapter 46. Pain Management: Acute and Chronic Pain ....................................................................................181
mv mv mv mv mv lc mv




Chapter 47. Pneumonia .......................................................................................................................................185
mv mv




Chapter 48. Sexually Transmitted Diseases and Vaginitis..................................................................................187
mv mv mv mv mv mv




Chapter 49. Substance Use Disorders .................................................................................................................190
mv mv mv mv




Chapter 50. Tuberculosis ....................................................................................................................................195
mv mv




Chapter51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, OtitisMedia, and Otitis Externa ................197
m
v m
v mv mv mv mv m
v mv mv mv




Chapter 52. Urinary Tract Infections ..................................................................................................................200
mv mv mv mv




Chapter 53. Women as Patients ..........................................................................................................................203
mv mv mv mv




Chapter 54. Men as Patients ................................................................................................................................207
mv mv mv mv




Chapter 55. Pediatric Patients .............................................................................................................................209
mv mv mv




Chapter 57. Geriatric Patients..............................................................................................................................213
mv mv lc

, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 mv mv mv mv Ch01
e

Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
mv mv mv mv mv lc lc mv mv lc




MULTIPLE CHOICE mv




1. Nurse practitioner prescriptive authority is regulated by:
mv mv mv mv mv lc



A. The National Council of State Boards of Nursing
mv mv mv mv mv mv mv



B. The U.S. Drug Enforcement Administration
mv mv mv mv



C. The State Board of Nursing for each state
mv mv mv mv lc mv lc



D. The State Board of Pharmacy
mv mv mv mv




ANS: m v m v C PTS: 1

2. Thebenefits tothepatient of having an advanced practiceregisterednurse (APRN) prescriber inc
mv mv mv mv mv mv mv mv mv mv



lude:
A. Nurses know moreabout pharmacology than other prescribers because they take it bo
mv mv mv mv mv mv mv lc mv lc lc m



th in their basic nursing program and in their APRN program.
v mv mv mv mv mv mv mv mv mv mv



B. Nurses care for the patient from a holistic approach and includethe patient in de
lc mv mv mv mv mv lc lc mv mv lc lc mv



cision-making regarding their care.
mv mv mv mv



C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
mv mv mv mv mv mv mv mv mv



D. APRNs are able toprescribeindependentlyin all states, whereas aphysician’s as
m
v lc m
v mv lc lc mv mv m



sistant needs to have a physician supervising their practice.
v mv mv mv mv mv mv mv mv




ANS: m v m v B PTS: 1

3. Clinical judgment in prescribing includes:
mv mv lc mv



A. Factoring in the cost to the patient of the medication prescribed
mv mv mv lc mv mv mv mv mv mv



B. Always prescribing the newest medication available for the disease process
mv lc mv lc mv mv mv mv lc



C. Handing out drug samples to poor patients lc mv mv mv mv mv



D. Prescribing all generic medications to cutcosts mv mv mv mv mv




ANS: m v m v A PTS: 1

4. The process for choosing an effective drug for a disorder includes:
mv mv mv mv mv mv mv mv mv m
v



A. Asking the patient what drug they think would work best for them
mv mv mv mv mv mv lc mv mv mv mv



B. Consulting nationally recognized guidelines for diseasemanagement mv mv mv lc mv



C. Prescribing medications that are available as samples before writing a prescription
mv mv mv mv mv lc mv mv mv mv



D. Following U.S. Drug Enforcement Administration guidelines forprescribing
lc mv mv mv mv mv




ANS: m v m v B PTS: 1

5. Nonintentional nonadherence of drug therapy may occur due to: mv mv mv lc mv mv mv mv



A. Belief that medication does not workmv mv mv mv mv



B. Adverse drug reactions mv mv



C. Chronic conditions that require dailytherapy mv mv mv mv



D. Forgetfulness ordistraction mv




ANS: m v m v D PTS: 1